![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GENTIUM S.P.A. ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION
GENTIUM S.P.A. ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION
July 27, 2005
Gentium S.p.A. (AMEX: GNT) (the "Company") announced that the underwriters of its initial public offering of June 16, 2005 have exercised their over-allotment option to purchase an additional 300,000 of the Company's American Depositary Shares (ADSs), at a price of $9.00. Gentium received gross proceeds of $2.7 million from the exercise of this option. To date, the underwriters have purchased a total of 2,700,000 ADSs. Maxim Group LLC and I-Bankers Securities Incorporated served as co-managers of the offering.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1020671XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct